WMB
68
-2
MPC
47
3
SCHW
65
-2
QCOM
55
-2
HRL
30
-3
FDX
54
14
PSA
58
5
HPE
70
2
NSC
64
2
IVZ
49
-3
AVY
53
2
EQT
57
-3
COF
63
-4
LNC
45
-4
MAT
38
-3
QRVO
4
-2
CHD
48
-3
BLK
70
-2
CI
52
-7
GS
75
-4
WMB
68
-2
MPC
47
3
SCHW
65
-2
QCOM
55
-2
HRL
30
-3
FDX
54
14
PSA
58
5
HPE
70
2
NSC
64
2
IVZ
49
-3
AVY
53
2
EQT
57
-3
COF
63
-4
LNC
45
-4
MAT
38
-3
QRVO
4
-2
CHD
48
-3
BLK
70
-2
CI
52
-7
GS
75
-4
Financhill
Back

Range Cancer Therapeutics ETF Vs. First Trust Nasdaq Pharmaceuticals ETF Industry Stock Comparison

Sell
44

CNCR
Range Cancer Therapeutics ETF

Last Price:
15.24
Seasonality Move:
1.85%
Sell
49

FTXH
First Trust Nasdaq Pharmaceuticals ETF

Last Price:
29.16
Seasonality Move:
4.52%
Sell
44
Range Cancer Therapeutics ETF (CNCR) is a Sell

Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?

  • The current Range Cancer Therapeutics ETF [CNCR] share price is $14.80. The Score for CNCR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
First Trust Nasdaq Pharmaceuticals ETF (FTXH) is a Sell

Is First Trust Nasdaq Pharmaceuticals ETF a Buy, Sell or Hold?

  • The current First Trust Nasdaq Pharmaceuticals ETF [FTXH] share price is $28.56. The Score for FTXH is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • FTXH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CNCR Stock Price Chart

What is Range Cancer Therapeutics ETF's stock price today?

  • The Range Cancer Therapeutics ETF share price today is $14.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNCR is experiencing selling pressure, which indicates risk of future bearish movement.

FTXH Stock Price Chart

What is First Trust Nasdaq Pharmaceuticals ETF's stock price today?

  • The First Trust Nasdaq Pharmaceuticals ETF share price today is $28.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FTXH is experiencing selling pressure, which indicates risk of future bearish movement.

CNCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 45.09 Sell
Chaikin Money Flow: -2025 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.73 - 15.45) Sell
Bollinger Bands (100): (14.08 - 15.46) Buy

FTXH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 49.28 Sell
Chaikin Money Flow: -3055 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.21 - 28.85) Buy
Bollinger Bands (100): (27.89 - 29.17) Buy

CNCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.36 Sell
20-day SMA: 15.14 Sell
50-day SMA: 15.08 Sell
200-day SMA: 15.09 Sell
8-day EMA: 15.24 Sell
20-day EMA: 15.16 Sell
50-day EMA: 15.03 Sell
200-day EMA: 14.63 Buy

FTXH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.67 Sell
20-day SMA: 28.48 Buy
50-day SMA: 28.71 Sell
200-day SMA: 27.83 Buy
8-day EMA: 28.68 Sell
20-day EMA: 28.59 Sell
50-day EMA: 28.6 Sell
200-day EMA: 27.9 Buy

Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

First Trust Nasdaq Pharmaceuticals ETF Earnings Growth & FTXH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Range Cancer Therapeutics ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

First Trust Nasdaq Pharmaceuticals ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):